Elliptic Laboratories ASA

OSE:ELABS.OL

17.56 (NOK) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) NOK.

2023202220212020201920182017
Operating Activities:
Net Income -38.001-39.302-13.092-15.557-16.96-33.236-43.48
Depreciation & Amortization 4.63711.3178.3115.4394.3932.1151.935
Deferred Income Tax 00-0.012-0.549-0.431-0.38-0
Stock Based Compensation 9.84212.46410.3494.0372.8723.7182.176
Change In Working Capital -20.3271.446-17.031-2.217-0.671-9.143-0.561
Accounts Receivables -20.118-11.469-28.599-0.451-0.742-10.56-1.827
Inventory 0000000
Accounts Payables 2.187-1.3612.040.154-1.6931.428-1.277
Other Working Capital -2.39614.2769.528-1.9211.764-0.0112.543
Other Non Cash Items 38.0841.3170.6532.172.7511.7681.062
Operating Cash Flow -42.812-12.758-10.822-6.678-8.047-35.158-38.869
Investing Activities:
Investments In Property Plant And Equipment -25.613-23.327-17.61-15.103-11.097-8.739-1.37
Acquisitions Net 0000000
Purchases Of Investments 0000000
Sales Maturities Of Investments 0000000
Other Investing Activites -20.457000000
Investing Cash Flow -25.613-23.327-17.61-15.103-11.097-8.739-1.37
Financing Activities:
Debt Repayment -4-4-4-250-25.007-2
Common Stock Issued 9.4952.972162.218125.0443.015050
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 3.663-3.233-11.418-12.85-4.62623.239-1.062
Financing Cash Flow 4.151-4.261146.887.1938.38923.23946.938
Other Information:
Effect Of Forex Changes On Cash 1.6370.4160.059-0.0470.005-0.058-0.139
Net Change In Cash -62.637-39.932118.42765.36219.25-20.7166.559
Cash At End Of Period 115.582178.219218.15199.72435.87316.62437.34